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Abstract 
Progesterone is a gonadal steroid that maintains pregnancy and prevents ripening 
of the cervix. Previous research has shown that progesterone has a strong binding affinity 
for both progesterone and glucocorticoid receptors. However, what is not known is the 
role these receptors play in the parturition process. The purpose of this study was to 
determine whether progesterone withdrawal promotes the neuroinflammatory processes 
within the pre-partum cervix through the actions of progesterone receptors. To test this, 
time-dated pregnant mice were subjected to pure agonists or a progestagen that binds to 
both receptors. Sections of cervix were analyzed to count resident immune cells and 
determine ripening within each cervix. Immune cell counts did not display any significant 
differences between the mice treated with the pure progesterone agonist and the mice 
treated with the mixed progestagen. Cell nuclei counts revealed a significant increase in 
cell nuclei of the pre-partum cervices treated with the pure progesterone agonist. Serum 
·progesterone levels behaved as expected. Further analysis of cervical tissue will be 
performed in order to improve the validity of the results found in this study. 
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Introduction 
Roughly 12.4% of the births in the U.S. today are premature births- a number 
that is strikingly higher than many other developed nations (Grady, 2009). A premature 
birth is defined as occurring before 3 7 weeks of gestation. While the reasons for the high 
premature birth rate in the U.S. are unclear, many believe the largest contributor is the 
increased number of late pre-term births, which refers to births occurring between 34 and 
36 weeks of gestation. Several factors are considered to contribute to late pre-term births 
including an increase in multiple births, a rise in assisted reproductive technologies, 
health insurance status, and an increase in women choosing to induce labor (Park et al., 
2009). While this last reason may seem unusual, women may choose to induce preterm 
labor in cases of a uterine infection, amniotic sac rupture, placental deterioration, and 
when the mother has medical conditions that could harm the baby, such as hypertension 
(Mayo Clinic, 201 0). 
Premature labor and birth have both been implicated in fetal morbidity and 
mortality (McDonald et al., 1996). One reason for this has to do with the development of 
the lungs while the fetus resides in the uterus. The lungs are the last organs in the 
mammalian fetus to fully develop. One vital step in lung maturation is the production of 
surfactant, a lipoprotein responsible for reducing the alveolar surface tension, which is 
necessary for respiration to occur (West eta!. , 1994 ). This and other vital steps in lung 
maturation must occur before the process of parturition in order for the infant to draw in 
its first breath. Failure for this to occur results in the death of the newborn due to 
deficient amounts of oxygen being delivered to the brain and other vital organs (Gilbert, 
2006). Lack of maturation prior to birth can also cause life-long illnesses, such as 
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Respiratory Distress Syndrome, Chronic Lung Disease, and even Cerebral Palsy (Fraser 
et al., 2004; 4MyChild, 201 0). Premature birth can also lead to delayed development and 
learning disabilities later in life (March of Dimes, 2009). 
Current management techniques for preterm labor are aimed at delaying birth 
once labor has already begun by treating the mother with anti-contraction medications 
known as tocolytics (Simhan et a!., 2007). Types of tocolytics include magnesium 
sulfate, which aims to stop uterine contractions by blocking neuromuscular transmission, 
and indomethacin, an agent used to stop the production of cytokines and halt the 
neuroinflammatory response (Von der Pool, 1998). Other methods attempt to speed up 
the maturation of the baby' s lungs through the administration of glucocorticoids, which 
are steroids capable of inducing the production of surfactant in the fetal lungs. However, 
these methods are not consistently effective and can result in side effects such as 
neuromotor and cognitive defects in the child (Yeh eta!., 2004). Since little is known 
regarding the physiological processes within the body that are responsible for causing 
preterm birth in humans, effective treatments to prevent, rather than just delay, preterm 
labor and birth have not been developed. 
During gestation, the rigid, collagen-rich cervix acts as a gatekeeper between the 
fetus and the outside world (Yellon et al., 2009). However, towards the end of pregnancy, 
the collagen within the cervix begins to break down. This degradation of collagen matrix, 
known as collagenolysis, causes the cervix to become more soft and elastic, allowing it to 
relax and dilate in preparation for the fetus to exit the vaginal canal. This process, known 
as cervical ripening, provides a safe and relatively easy way for the fetus to travel through 
the cervix (Leppert et al., 1995). Failure of the cervix to ripen and remodel can result in 
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dystocia, or difficult labor, and make vaginal births very painful or impossible for the 
mother (Cunningham et al., 2009). During the time that the cervix is preparing to open, 
the uterus simultaneously begins to experience increased contractility. These muscle 
contractions are essential for pushing the fetus through the cervical opening (Mackler et 
al., 1999). 
Progesterone is a female gonadal hormone that plays a vital role in maintenance 
of pregnancy and prevention of preterm labor. One way that it does this is by inhibiting 
ripening of the cervix (Chwalisz et al., 1991 ). In fact, research suggests that progesterone 
alone is capable of maintaining pregnancy without the aid of estrogen (Luque et al. , 
1996). Studies have shown that removing the source of progesterone induces parturition 
in animals such as rabbits and mice. In these studies, this removal usually comes in the 
form of removing the ovaries. However, the source of progesterone in humans is not 
actually ever removed when the process of parturition begins. In fact, the plasma levels of 
progesterone in women who are giving birth are maintained at high levels until the 
placenta is expelled, suggesting an apparent lack of actual withdrawal of progesterone in 
humans. This has led to the formulation ofthe idea of"functional progesterone 
withdrawal" in humans. This idea simply states that although systemic progesterone 
levels remain high in the body, the uterus and cervix gradually lose the capability to 
respond to progesterone' s effects, and as a result cervical ripening occurs (Zakar et al., 
2007). The causes underlying functional progesterone withdrawal are unknown, but 
several theories exist including catabolism of progesterone in the uterus into inactive 
compounds, alterations in the progesterone receptor isoform ratios, and changes in 
cofactor protein levels affecting progesterone receptor activation (Brown et al, 2005). To 
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mimic the idea of human functional progesterone withdrawal in mice studies, removal of 
the progesterone source through ovariectomies must occur. Therefore, the term 
progesterone withdrawal throughout the paper will refer to both systemic progesterone 
withdrawal, as well as functional progesterone withdrawal, depending on the species in 
question. 
Upon the withdrawal of progesterone, cervical ripening takes place, resembling an 
inflammatory process in which immune cells, specifically macrophages and neutrophils, 
migrate into the cervix. (Yell on et al., 2009). Increased activity of macrophages has been 
correlated with the breakdown of collagen in the cervix. This may be attributed to 
macrophages increasing their production of both collagenase, an enzyme that breaks the 
peptide bonds within collagen, and cytokines, chemo-attractant proteins produced and 
secreted by immune cells (Busiek et al., 1995). When macrophages become activated, 
they produce these pro-inflammatory cytokines, such as interleukin-6 (IL-6) and 
interleukin-8 (IL-8), both of which are responsible for leukocyte recruitment in the cervix 
(Madigan et al., 2005). As a result of this cell signaling, the inflammatory response 
within the cervix is amplified. While other leukocytes, such as neutrophils, are also 
present in the womb during gestation, macrophages appear to be the most prevalent and 
abundant type of immune cell found in the uterus and cervix. Enzyme digestion of the 
pregnant murine, or rodent, uterus provides some evidence for this, showing that 
macrophages comprise 22% of cells in the pregnant murine uterus as compared to only 
10% macrophage composition in a non-pregnant murine uterus (Hunt et al., 1985). In the 
mouse cervix, the greatest number of macrophages is seen on Day 18, the day directly 
preceding parturition (Mackler et al., 1999). 
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However, less research has focused on immune cell counts in the human uterus 
and cervix. One such study focused on the relationship between cytokine production and 
cervical ripening in humans, in which they found that cervical ripening correlates with an 
increase in cytokines within the cervix, specifically IL-6 and IL-8 . The study attributed 
the cytokine production mostly to neutrophils, however no measurement or identification 
of neutrophils in the cervix was ever used in the study. In addition, macrophages are also 
capable of secreting IL-6 and IL-8 (Sennstrom et al., 2000). Therefore, the possibility 
that the increase in cytokines seen in this study was due to an increase of macrophages in 
the cervix, rather than, or in addition to, neutrophils, cannot be excluded. In addition to 
the link seen between withdrawal of progesterone and migration of immune cells into the 
womb, the presence of progesterone has also been seen to inhibit immune cell function in 
the ovine, or sheep, uterus (Padua et al. , 2005). This suggests that not only does 
progesterone prevent the migration of active immune cells into the uterus and cervix; it 
also prevents the inflammatory activity of immune cells already residing in these areas. 
Human studies have also shown the existence of progesterone receptors on macrophages 
using RT-PCR and immunohistochemistry, supporting the idea that immune cells 
respond to the presence or absence of progesterone (Khan et al., 2005). 
Location and activity of macro phages can be analyzed using several different 
methods. One such method utilizes interstitial cell adhesion molecule (ICAM-1), which is 
a protein displayed on the surface of active macrophages. It has been observed that 
macrophages in the womb of laboring women express ICAM-1 at an increased rate, 
indicating a correlation between increased activity of macrophages and the process of 
labor (Ledingham et al. , 2001 ). Macrophages and other leukocytes also display CD 
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marker proteins on their surfaces that can be indicated through the use of antibodies. 
(Mackler et al., 2000). For example, BM8 is a macrophage marker protein located in the 
membrane ofthe cell (Abeam, 2010). Another method to visualize and identify 
leukocytes is to track the release of cytokines, such as the aforementioned IL-6 and IL-8, 
by using substances that can bind to these cytokines and then be visualized. Although 
these techniques allow researchers to obtain information regarding the leukocyte 
infiltration and inflammatory processes occurring in the cervix during cervical ripening 
and parturition, exactly how progesterone affects these neuroinflammatory actions is 
unknown. 
The classically accepted mechanism of progesterone action involves a genomic 
pathway involving nuclear progesterone receptors . It is hypothesized that progesterone 
binds to nuclear receptors on the cell nuclei of the cervix and uterus altering gene 
expression, which leads to maintenance of pregnancy (Ashley et al., 2009). Two known 
isoforms ofthe nuclear progesterone receptors exist in humans: hPR-A and hPR-B. The 
hPR-B isoform is 164 amino acids longer than the hPR-A, however their difference in 
function is not completely clear. Research has supported the idea ofhPR-B functioning as 
a transcriptional activator, while hPR-A acts as a dominant negative repressor ofhPR-B 
in some ways (Giangrande et al., 2000; Smith et al.,2002). Further studies are currently 
being performed and analyzed in order to better understand the specific functions that 
each nuclear isoform plays in maintenance of pregnancy. 
Recent studies have illustrated the ability of progesterone to produce stimulatory 
effects that occur too rapidly to be a result of nuclear progesterone receptor action. This 
suggests the existence of cell membrane progesterone receptors (mPR's) that are also 
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involved in mediating the effects of progesterone (Ashley et al., 2009). This mPR has 
been seen in several different animals including the sheep, seatrout, and humans (Dong et 
al. , 201 0). It is believed that the rapid response of the membrane progesterone receptors 
occurs through the non-genomic actions of signal transduction pathways. Recent studies 
regarding membrane progesterone receptors have verified that progesterone is in fact the 
ligand for mPR. These studies have also investigated the changing of mPR expression in 
regards to the estrous cycle stages, showing that the expression of mPR in the ovine 
corpus luteum and uterus was correlated to the different estrous cycle stages (Ashley et 
al., 2009). Discovery and analysis of membrane progesterone receptors are relatively new 
and thus little is known about their role in maintenance of pregnancy. 
Additional research has illustrated that the progesterone hormone and other 
hormones within the progestagens group, such as medroxyprogesterone acetate, possess a 
strong binding affinity for both progesterone receptors and glucocorticoid receptors 
(Pasqualini et al. , 2007). Progestagens are variants of progesterone (Merriam-Webster 
Online, 201 0). Progesterone is a steroid hormone and as such, contains the characteristic 
4-ring structure with specific substituents. Glucocorticoids are also steroid hormones with 
a similar structure and as a result, progesterone and other progestatens are capable of 
weakly mimicking the actions of glucocorticoids (Ganguly et al., 1981 ). 
Medroxyprogesterone acetate is an artificial chemical that has been shown to forestall 
inflammation-induced cervical ripening (Yell on et al., 2009). In addition, treatment with 
the pure progesterone receptor agonist, promegestone (R5020), was successful at 
maintaining an unripe cervix in pregnant rats (Shi et al., 2000). This means that a 
compound capable of binding only to progesterone receptors was able to maintain 
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pregnancy, implying that progesterone receptors specifically play a role in the 
maintenance of pregnancy. Dexamethasone, a pure corticosteroid capable of binding only 
to glucocorticoid receptors, was used to treat pregnant rabbits in order to investigate its 
role in determining gestational length. Researchers found that treatment with 
dexamethasone in the rabbits resulted in premature delivery (Challis et al., 1975). 
However, in a small trial study of pregnant women treated with corticosteroids, no 
premature induction of labor or cervical ripening was seen (Kavanaugh et al., 2006). 
Thus far, there is no clear evidence explaining the role, if any, of corticosteroids and 
glucocorticoid receptors in the maintenance of pregnancy and an unripe cervix or cervical 
ripening and the induction of labor. 
Mice share many of the same complex physiological systems that humans 
possess, such as reproductive, immune, endocrine, and nervous systems. In addition to 
these systems, mice share similarities with the human uterus such as containing different 
isoforms of progesterone receptors. For these reasons, the mouse has enough 
commonalities with human physiology to serve as a practical model for this study. In 
addition, mouse species tend to have a very predictable gestational period, which is 
generally around 19-21 days depending on the strain ofthe mouse (NHGRI, 2002). This 
enables researchers to predict outcomes regarding pregnancy and, specifically for this 
research project, induce artificial preterm labor. The CD-1 mouse strain that was used in 
this study has a normal gestational period of 19 days. One reason this strain was 
particularly useful for this specific study is because this strain had produced predictable 
results in previous studies regarding maintenance of pregnancy and parturition day using 
promegestone (R5020) (Philibert et al., 1999). R5020 is a pure progesterone receptor 
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agonist that was used as a progesterone replacement in this study. The CD-1 strain was 
chosen for this project because previous studies defined the mode and doses for both the 
progesterone and estradiol concentrations to sustain pregnancy following ovariectomy. 
This specific study explored if the progesterone receptor was responsible for the 
maintenance of pregnancy, sustains an unripe cervix, inhibits immune cell migration. It is 
likely that when the responsible receptor is bound, it causes physiological reactions, such 
as suppression of macrophage activity in the cervix, to take place that prevent the 
processes leading up to parturition. However, it may be possible that the bound receptor, 
whether it be the progesterone receptor or the glucocorticoid receptor, is responsible for 
activation of macrophages and other immune cells, resulting in the inflammatory 
processes that lead to cervical ripening once progesterone withdrawal occurs. These 
findings would suggest that progesterone acts as an inhibitor to the receptor, and when 
the receptor is unbound, it may initiate cervical ripening. The overall goal of this project 
was to investigate the role of progesterone receptors and glucocorticoid receptors in the 
determination of gestational length. 
Progesterone treatment has been shown to maintain pregnancy by itself and as a 
result, it is likely that presence of progesterone mediates its effects through the 
progesterone receptor. In turn, it is also likely that the withdrawal of progesterone 
mediates the effects of cervical ripening and parturition through the progesterone receptor 
as well. However, because of progesterone's ability to bind glucocorticoid receptors 
tightly, the option that glucocorticoid receptors may play a role in maintenance of 
pregnancy must also be explored. Therefore, the hypothesis tested in this experiment was 
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that progesterone receptors exclusively mediate the neuroinflammatory processes that 
result in remodeling of the cervix and parturition. 
Experimental Design and Methods 
Animals, Surgeries, and Treatments 
Time-dated pregnant CD-1 mice were ordered from Harlan-Sprague Dawley and 
delivered to the lab on day 15 of gestation. Surgery was performed on day 16 of gestation 
to eliminate the source of natural progesterone and estrogen. Mice were anesthesized 
with isofluorine, a portion of the back shaved below the last rib, and skin cleaned with 
ethanol and betadine. Ovariectomies were then performed by making a small incision in 
the skin of the mouse's back and making a second small incision in the interperitoneal 
cavity wall directly below the first incision. The ovary appears as a small, follicle-filled 
pink sphere in a white fat mass and was easily visible through the peritoneal wall and 
after incision. To remove the ovary, the uterine tube was ligated, then cut just below the 
ovary using surgical scissors. This procedure was repeated on the opposite side. The 
peritoneal cavity wall was then sutured. Silastic capsule implants were inserted 
subcutaneously, after which the skin was stapled back together. These surgeries have no 
apparent effect on the offspring viability (Yell on et al., 2009). 
There were five different groups of mice distinguished by the treatment they 
received following the bilateral ovariectomy. The first group was a Sham group that did 
not actually have their ovaries removed, but were subjected to the same physical stress of 
the surgery including preparation, incisions, peanut oil-filled vehicle implants, stitches, 
and staples. The Sham group served as the control group for normal cervical remodeling 
and time of birth. Pups in this group were expected to present on the morning of day 19. 
12 
The second group was an OvxN control group, which consisted of mice who had their 
ovaries removed and were then treated with a vehicle, which consisted of a capsule filled 
with peanut oil. This group was intended to mimic a pre-term labor and birth group. The 
third group was the Ovx/E±P control group. These mice had two estrogen capsules and 
three progesterone capsules implanted following the ovariectomy. Description of the 
capsules is presented below. On day 18 of gestation, the three progesterone capsules 
were removed, which initiated the parturition process. The fourth group was treated with 
an injection of the progesterone agonist R5020 (Ovx/R5020) at a concentration of 12 
mg/kg/day (Philibert et al. , 1999). It should be noted that R5020 binds strongly to the 
nuclear progesterone receptor, but not to the membrane progesterone receptor (Dong et 
al., 2010). The fifth group was injected with a mixed progesterone/glucocorticoid 
receptor agonist known as medroxyprogesterone acetate. This group was referred to as 
Ovx/MPA and received treatment at a concentration of 10 mg/kg/day (Elovitz et al., 
2004). Progesterone capsules in the Ovx/E±P group were removed on day 18 (Table 1) to 
reduce systemic progesterone concentrations and induce parturition. 
T bl 1 P b d. d . h a e . ost ree mg ay treatments, cervix arvest (X) db. h , an Irt 
Group Day 16 Day 16.5 Day 17 Day 18 Day 18.5 
Sham Control Surgery X (PreP) X (PreP) X (PreP) 
OvxN Control Surgery X (PreP) X (PP) 
Ovx/E±P Control Surgery X (PreP) X; -P X (PreP) 
(PreP) 
Ovx/R5020 Surgery X (PreP) X (PreP) X (PreP) 
Ovx/MPA Surgery X (PreP) X (PreP) 
Ovx =day of ovanectomy, +=treat,-= Withdraw, E =estradiOl, P =Progesterone, 
R5020 = promegestone, MPA= medroxyprogesterone acetate, 
PP = post partum, PreP = pre partum, X = harvesting of the cervix 
Day 19 
X (PP) 
X (PP) 
X (PP) 
X (PP) 
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Capsule Preparation 
Silastic tubing (1.57rnrn inside diameter x 3.18 rnrn outside diameter-
manufactured by Corning) and polyethelene tubing (1.57 rnrn inside diameter x 2.08 rnrn 
outside diameter - manufactured by Clay Adams) were cut in order to construct steroid-
filled silastic capsules. One end of the tube was heat-sealed using the tip of a hot glue 
gun. Vehicle capsules were 1 ern long and injected with plain peanut oil, which was the 
solvent used to dissolve the other substances used. Progesterone was dissolved in peanut 
oil in a concentration of 1 g/rnL and injected into the unsealed end of a 1 ern silastic 
capsule. Estradiol was dissolved in peanut oil to a concentration of 10 j..tL/rnL and 
injected into the unsealed end of a 2 ern silastic capsule. Capsules were then heat-sealed 
at the end of injection and washed in 90% ethanol in order to sterilize. A 24-hour 
incubation period in phosphate buffer saline (PBS) prior to implantation was performed 
in order to create a salt balance and pH balance that allowed successful implantation of 
the capsule. The beginning of this study was dedicated to determining the types and 
amount of capsules that produced serum concentrations capable of maintaining 
pregnancy in the mice. Research has previously reported that these capsules are capable 
of sustaining pregnancy in mice (Sharma eta!. , 1983 ). However, the actual serum 
concentrations of progesterone and estrogen during late pregnancy in mice were 
unknown and were measured in this study by drawing blood from the heart before the 
cervix was excised. 
Tissue Collection and Processing 
Following ovariectomies and implant treatments, mice were euthanized using C02 
gas on days 16.5, 17, 18, 18.5, or 19 as seen in the table above. In the Ovx/E±P control, 
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progesterone was removed from animals that had not yet been sacrificed in order to 
induce the process of cervical ripening. The abdomens of the mice were cut so as to 
access both the abdominal cavity and the thoracic cavity. Blood was drawn from the heart 
and serum frozen for later assay of progesterone and cortical concentrations. The cervix, 
attached to roughly 1 mm of the lower portions of the left and right uterine horns, was 
excised and post-fixed in 4% paraformaldehyde. The preserved tissue was sent to a 
histotechnician in the Lorna Linda Department of Anatomy in order to embed the tissue 
in paraffin wax blocks. This allowed for easier sectioning of the tissue. Once embedded, 
the tissue was sectioned in 1 0 11m frontal sections and mounted on slides. 
Immunohistochemical Staining 
The prepared slides were stained for collagen content using picrosirius red, 
stained for cell nuclei counts using a hematoxylin counterstain, or processed by 
immunohistochemistry for macrophages and neutrophiils. The process of staining for 
macrophages will be explained in detail since macrophage counts will provide the main 
data used to determine cervical ripening trends. Deparaffinization was performed by 
baking the slides at 60°C for 30-60 minutes. This was followed by two 1 0-minute 
incubations using xylene, two 3-minute washes in 100% ethanol, and two 3-minute 
washes in 90-95% ethanol. Next, the slides were incubated for two 3-minute washes in 
70-75% ethanol and finished with one 30-second rinse in deionized water. A pap pen was 
then used to create a water resistant boundary around the tissue sections, followed by 
incubation with proteinase K for 2-minutes. Then 3% hydrogen peroxide was added for 
15 minutes followed by three 5-minute washes with PBS. The slides were then incubated 
with BM8 primary antibody in a 1:800 concentration for 90 minutes and rinsed with PBS 
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for three 5-minute periods. Next, the slides were incubated with biotyinylated anti-rat 
secondary antibody in a 1:100 concentration for 30 minutes. Three additional 5-minute 
PBS washes were performed. Compounds known as ABC and DAB substrate were added 
with PBS washes in between. Hematoxylin staining occurred for 2 seconds. The slides 
were then rinsed in running water for 15 minutes . Lastly, the tissue was dehydrated by 
two 5-minute rinses with 75% ethanol, two 5 minutes rinses in 95 % ethanol , two 5 
minutes rinses in 100% ethanol, and two 1 0-minute rinses in xylene. 
Analysis of Data 
Once the slides had been stained, pictures were taken of the tissues using the 
Zeiss microscope and the Spot Advanced program. For the macrophage and neutrophil 
stained tissues, a total of 24 pictures of each animal cervix were taken. Three different 
tissue sections from the same animal were chosen and eight non-overlapping pictures 
were taken within each tissue section in order to obtain pictures that were representative 
of the entire cervix. 
Pictures were then uploaded and analyzed on the Image Pro Plus 6.0 program. 
Collagen content was counted manually. However, macrophage counts and neutrophil 
counts were automatically counted using the program based on color, shape, and size. 
Counts were then compiled into an Excel sheet and analyzed using the Graph Pad Prism 
statistical computer program. A one-way ANOV A and an unpaired t-test were used to 
determine whether there statistically significant differences existed between the six 
groups. 
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Results 
Normal 
Term Birth 
Surgery 
Sham Ovx/V E-P R5020 MPA 
Figure 1. Parturition day of mice subjected to a sham surgery, an ovariectomy (Ovx), an 
ovariectomy followed by estrogen and progesterone treatment, an ovariectomy followed by 
R5020 treatment, an ovariectomy followed by MPA treatment, or an ovariectomy followed by 
. dexamethasone treatment. Each bar represents the mean day of birth (±SE, number of mice/group 
specified). Where SE not shown, all births occurred on the day indicated. * indicates p<O.OS 
versus sham control. Date of surgery indicated by red line, while normal term birth in blue line is 
based upon previous reports (Mackler eta!., 1999). 
Mice in the Sham control group delivered on both Day 18 and Day 19. Expected 
results based on the hypothesis were seen in the Ovx control group, which delivered on 
Day 17, as well as the Ovx/E-P3 group, which delivered on Day 19 similar, but not 
identical, to the sham control. The Ovx/R5020 group experienced parturition on day 19 
as expected. The Ovx/MPA group delivered on both Day 18 and Day 19, much like the 
Sham group, and the Ovx/Dex group delivered on day 17 (Figure 1). A one-way ANOVA 
of the data revealed that both the OvxN group and the Dex group were statistically 
different from the Sham control. 
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Figure 2. Serum progesterone concentrations of non-pregnant mice or mice subjected to a sham 
surgery, an ovariectomy (Ovx), an ovariectomy followed by estrogen (E) and progesterone (P) 
treatment, an ovariectomy fo llowed by R5020 treatment, or an ovariectomy followed by MPA 
treatment. Each bar represents the mean serum progesterone concentration (±SE, number of 
mice/group specified). The x-axis indicates the day during gestation that serum levels were 
measured. a indicates p<0.05 versus Non-pregnant. b indicates p<0.05 versus day 16.5 within 
each group. c indicates p<0.05 versus day 17/18 within each group. d indicates p<0.05 versus day 
18.5/ 19 within each group . # indicates p<0.05 versus sham control across groups. + indicates 
p<0.05 versus E+P/E-P across groups. The x-axis indicates the day postbreeding that serum 
concentrations were measured. 
Serum progesterone concentrations displayed expected results (Figure 2). The 
Sham group shows a gradual decrease in serum progesterone concentrations as gestation 
progresses. The Ovx/V and MP A groups display low concentrations of serum 
progesterone immediately following ovariectomies and throughout the rest of the 
gestational period. The E+P/E-P group shows a progressive decline in progesterone 
concentrations, much like the sham control, and also illustrates the characteristic drop in 
progesterone levels on day 18 -the day when macrophage recruitment in the cervix is the 
highest. The R5020 group displays low concentrations of progesterone immediately 
18 
following ovariectomies and throughout the remainder of gestation, much like the OvxN 
group (Figure 2). 
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Figure 3. Serum corticosterone concentrations of mice subjected to a sham surgery, an 
ovariectomy (Ovx), an ovariectomy followed by treatment with estrogen (E) and progesterone (P) 
treatment, an ovariectomy followed by R5020 treatment, an ovariectomy followed by R5020 
treatment, or an ovariectomy followed by MPA treatment. Each bar represents the mean serum 
corticosterone concentration (±SE, number of mice/group specified). (d#) indicates the day 
during gestation that serum levels were measured . b indicates p<0.05 versus day 16.5 within each 
group. c indicates p<0.05 versus day 17/ 18 within each group. d indicates p<0.05 versus day 
18.5/19 within each group.# indicates p<0.05 versus sham control. • indicates p<0.05 versus 
OvxN. +indicates p<0.05 versus E+P/E-P across groups.+ indicates p<0.05 versus R5020. The 
x-axis indicates the day postbreeding that serum concentrations were measured . 
Statistical analyses performed on the serum corticosterone concentration data 
reveal a decrease in corticosterone concentrations following parturition in the Sham, 
OvxN, and E-P groups (Figure 3). However, this decrease following parturition is not 
seen in the R5020 or MPA groups. The R5020 group actually appears to display an 
increase in serum corticosterone concentrations following parturition. Statistical analysis 
of the R5020 and MP A groups also fails to show any significant differences between 
these groups and the Sham control (Figure 3). 
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Figure 4. Cell nuclei counts for pre-partum and post-partum groups of mice subjected to a sham 
treatment, ovariectomy (Ovx), ovariectomy followed by estrogen (E) and progesterone (P) treatment, 
ovariectomy followed by R5020 treatment, or an ovariectomy followed by MPA treatment. Each bar 
represents the mean cell nuclei counts per )lm3 oftissue. (±SE, number of mice/group specified). 
* indicates p < 0.03 between R5020 and E-P. Sham pre-partum refers to gestational day 17, while 
sham post-partum refers to gestational days 18 and 19. Ovx/V pre-partum refers to gestational day 
16.5, while Ovx/V post-partum refers to gestational day 17. E-P pre-partum refers to gestational day 
18.5, while E-P post-partum refers to gestational day 19. R5020 pre-partum refers to gestational day 
18, while R5020 post-partum refers to gestational day 19. MPA pre-partum refers to gestational day 
18, while MPA post-partum refers to gestational day 18.5. 
Cell nuclei counts appear to show an increase in cell nuclei numbers in both the 
R5020 pre-partum and post-partum groups (Figure 4) . A one-way ANOVA performed 
within Pre-partum group indicated a significant difference between the E+P group and 
the R5020 group (p = 0.0275). However, no other statistical differences were found 
within the pre-partum group or within the post partum group. A t-test was performed 
across groups, comparing respective pre-partum and post-partum groups. For example, 
the pre-partum R5020 was statistically compared to the post-partum R5020 group. No 
significant differences were found (Figure 4 ). 
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Figure 5. Macrophage counts of pre-partum and post-partum groups of mice subjected to a sham 
treatment, an ovariectomy (Ovx), and ovariectomy followed by estrogen (E) and progesterone (P) 
treatment, an ovariectomy followed by R5020 treatment, or an ovariectomy followed by MPA 
treatment. Each bar represents the mean macrophage counts normalized to cell nuclei counts per 
f.Lm 3 of tissue (±SE, number of mice/group specified).¥ indicates p< 0.04 between the pre-partum 
MPA group and the post-partum MPA group. Gestational days for the pre-partum and post-partum 
groups are the same as in Figure 4. 
Macrophage counts display expected trends for the most part (Figure 5). For the 
OvxN, E-P, R5020, and MPA groups, a decreasing trend in normalized macrophage 
numbers appears to occur from pre-partum to post-partum. However, statistical analysis 
between the pre-partum and post-partum groups for the Sham, Ovx/V, E-P, and R5020 
using an unpaired t-test indicated no statistical differences. On the other hand, an 
unpaired t-test comparing the pre-partum and post-partum MPA groups revealed a 
significant decrease in macrophages in the post-partum uterus (p = 0.0347). A one-way 
ANOV A within the pre-partum group showed no significant differences between the 
groups. Significant differences within the post-partum group were also not seen using a 
one-way ANOV A (Figure 5). 
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Discussion 
Findings in this study support the hypothesis that progesterone receptors solely 
mediate the effects of progestational agents to sustain an unripe cervix and forestall 
cervical ripening. This was shown by the ability of R5020, a chemical that can bind only 
to progesterone receptors, to maintain pregnancy. Furthermore, R5020 has a strong 
binding affinity to only the nuclear progesterone receptor, indicating that the nuclear 
progesterone receptor alone can mediate processes that delay parturition to normal term. 
To determine if the progesterone receptor alone was capable of 
maintaining pregnancy, the observed parturition days of each group were compared 
(Figure 1). Mice subjected to a Sham surgery gave birth on both days 18 and 19. Mice 
receiving no treatment were expected to experience normal gestation and parturition to 
take place on day 19 post-breeding (Philibert et al., 1999). However, delivery on day 18 
as well did not prevent conclusions regarding the ability to maintain pregnancy from 
being made. Because mice in the Sham group did not have their ovaries removed, the 
observed day of parturition was a result of natural progesterone and natural processes 
within the body. Based on this information and the statistical analyses performed versus 
the Sham control, the E+P/E-P, R5020, and MPA groups displayed the abi lity to maintain 
pregnancy through term and removal of these substances induced cervical ripening 
(Figure 1). 
Serum progesterone concentration assays revealed low progesterone 
concentrations for both the R5020 and MP A treatment groups following ovariectomies 
(Figure 2). This was expected since the natural source of progesterone was removed and 
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replaced with artificial chemicals that neither contain progesterone nor cross-react with 
the progesterone assay. These findings indicate that synthetic chemicals unable to sustain 
circulating progesterone concentrations were still capable of sustaining the progestational 
effects of progesterone and maintaining pregnancy. Furthermore, both of these chemicals 
were capable of binding to the progesterone receptor, supporting the idea that the 
progesterone receptor is responsible for maintenance of pregnancy. 
The ability of R5020 to maintain pregnancy indicates that an artificial chemical 
that binds only to nuclear progesterone receptors was able to maintain pregnancy. This 
means two things- that a progesterone receptor mechanism alone is responsible for 
maintaining pregnancy and that this mechanism occurs through the nuclear progesterone 
receptor and not the membrane progesterone receptor. Therefore, it can be concluded that 
the effects ofthe membrane progesterone receptor mentioned earlier are not vital in the 
processes that maintain pregnancy (Dong et al., 201 0). This conclusion allows future 
research involving preterm birth to be focused on nuclear progesterone receptors and the 
mechanisms by which they maintain pregnancy. 
In order to obtain information regarding the mechanism by which R5020 
maintains pregnancy, cell nuclei counts and macrophage counts were performed. R5020 
treatment resulted in an increase in cell nuclei numbers, contrary to what is normally 
observed (Figure 4). The hypertrophy of the cervix as gestation progresses generally 
results in a decrease in cell nuclei numbers per unit of cervical tissue. However, a 
significant increase in cell nuclei numbers was observed in mice treated with R5020, 
suggesting that R5020 maintains pregnancy through a mechanism that increases the 
number of cell nuclei within the cervix. Whether or not this increase in cell nuclei has 
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adverse effects on the pregnancy is unknown. Further research must be conducted in 
order to determine the implications of this increase in cell nuclei numbers. 
Macrophage counts for mice treated with R5020 were not statistically significant 
from the Sham control (Figure 5). This indicates that the number of macrophages 
recruited within the cervix during a normal mouse pregnancy did not differ significantly 
from the number of macrophages recruited within the cervix of a mouse treated with 
R5020. This further suggests that the mechanism by which macrophage recruitment 
within the cervix occurs in these two treatment groups may be the same or similar. 
Therefore what is known about the mechanism of R5020 is that it increases the number 
of cell nuclei present within the cervix and behaves similarly to the Sham control in 
regards to macrophage recruitment. 
The significance of MP A being able to bind to both progesterone and 
glucocorticoid receptors is that it is possible that MP A exerted its pregnancy maintenance 
effects through the combined actions of both receptors. Based on this, the next question 
researchers asked was whether R5020 and MPA acted through the same mechanism to 
maintain pregnancy. To determine if a difference in mechanism existed, researchers 
looked at both cell nuclei counts and macrophage counts. As mentioned earlier, R5020 
appears to increase cell nuclei numbers within the cervix. However, statistical analysis 
revealed no difference between the cell nuclei counts of the R5020 and MP A groups, 
indicating that the pregnancy maintenance mechanism of each compound did not differ 
with respect to cell nuclei numbers (Figure 4). When comparing macrophage counts of 
the MP A and R5020 pre-partum groups, no statistical difference was seen between the 
two, indicating that macrophage recruitment does not differ in cervices treated with these 
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two chemicals. These results suggest that the mechanisms by which these R5020 and 
MP A maintain pregnancy do not differ with respect to the cell nuclei numbers or the 
recruitment of macrophages. However, it is still possible that the mechanisms may differ 
with respect to collagen breakdown or nerve fibers and further analysis must be done to 
determine if these two mechanisms truly are the same. If so, researchers could conclude 
that MP A maintains pregnancy solely through the nuclear progesterone receptor just as 
R5020 does. 
Less in known regarding corticosterone levels throughout gestation. Therefore, 
expected results were not established prior to the assays. A spike in corticosterone 
concentrations is seen immediately following surgery in the OvxN, Ovx/E±P, and 
Ovx/R5020 groups (Figure 3). This spike may be a result of the surgery, but this is 
unlikely since it does not occur in the Ovx/MPA group as well. Pre-partum days 18, 18.5, 
and 19 are similar for all groups indicating that the specific treatments do not affect the 
pre-partum corticosterone concentrations. This provides further evidence that the 
glucocorticoid receptor does not play an integral role in the processes leading up to 
parturition. 
Several animals that were used in this study have yet to be analyzed. As a result, a 
lack of data prevents solid conclusions from being made at this point, but trends and 
statistical differences can be seen and explored. In addition some cervices were preserved 
better than others, meaning that the tissue was easier to section and visualize. In some 
cases, cervices were not fully intact and as a result, some the images being analyzed had 
"holes" in the tissue. This was avoided for the most part by using parts of the cervix that 
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were intact for analysis, but in cases where this was unavoidable, cervices were analyzed 
as accurately as possible. 
Further analysis is necessary to determine if progesterone is acting only through 
the progesterone receptor alone, or if it is capable of acting through the combined actions 
of both the progesterone receptor and the glucocorticoid receptor. Collagen and nerve 
fiber data have yet to be collected and analyzed. These data may provide some insight 
into possible differences between the mechanisms of R5020 and MP A, as well as provide 
useful information regarding the mechanisms involved in pregnancy. Once concrete 
conclusions can be drawn based on the results of this study, future studies can be aimed 
at determining if pure progesterone agonists, such as R5020, work through the same 
mechanisms to maintain pregnancy as progesterone. In addition, it would be useful to 
determine the exact role, if any, that the membrane progesterone receptors play in the in 
pregnancy and the specific pathways by which these mPR's work. If and when future 
studies do establish the mechanism by which both normal term and pre-term pregnancy 
occurs, pharmacological studies can be used to determine possible ways to prevent pre-
term birth from occurring. 
In summary, the results of the present study demonstrate that the nuclear 
progesterone receptor alone is capable of maintaining pregnancy. In addition, these 
results exhibit the ability of an artificial chemical to maintain pregnancy. This result 
suggests that treatment with R5020 may have the ability to forestall preterm birth in 
humans. Determining the mechanism by which R5020 prevents preterm birth will not 
only be important in understanding of the physiological processes involved in pregnancy, 
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but has implications in decreasing the rate of preterm births and improving neonatal 
outcome in the future. 
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